The pharmaceutical industry is a key partner in Europe’s fight against disease, developing new treatments and cures for patients across Europe. It is imperative that Europe remains a competitive destination for medical research and development by maintaining, sustaining and developing a predictable, robust regulatory and innovation-supportive incentives environment.

The aim of the LEVITATE project is to develop a new impact assessment framework to enable policymakers to manage the introduction of connected and automated transport systems, maximise the benefits and utilise the technologies to achieve long-term visions and goals. An essential part of this work seeks to forecast societal level impacts of connected and automated transport systems (CATS). These include impacts on safety, environment, economy and society.